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Abstract
Background Autologous chondrocyte implantation (ACI)
represents a valid surgical option for symptomatic full-
thickness chondral lesions of the knee. Here we report
long-term clinical and MRI results of first-generation ACI.
Materials and methods Fifteen patients (mean age
21.3 years) underwent first-generation ACI for symp-
tomatic chondral defects of the knee between 1997 and
2001. The mean size of the lesions was 5.08 cm2 (range
2–9 cm2). Patients were evaluated using the International
Knee Documentation Committee (IKDC) Knee Examina-
tion Form, the Tegner Activity Scale, and the Knee Injury
and Osteoarthritis Outcome Score (KOOS). High-resolu-
tion MRI was used to analyze the repair tissue with nine
variables (the MOCART scoring system).
Results The mean follow-up period was 148 months
(range 125–177 months). ACI resulted in substantial
improvements in all clinical outcome parameters, even as
much as 12 years after implantation. A significant decrease
in the MOCART score was recorded at final measurement.
Reoperation was required in 2 patients; failure was caused
by partial detachment of the graft in both cases.
Conclusion Autologous chondrocyte implantation is an
effective and durable solution for the treatment of large,
full-thickness cartilage and osteochondral lesions, even in
young and active middle-aged patients. High-resolution
MRI is a useful and noninvasive method for evaluating the
repaired tissue.
Level of evidence IV.
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Introduction
Cartilage lesions of the knee in orthopedic patients are an
underestimated problem. Despite the advances made in
scientific knowledge and technology, treatment of these
lesions remains troublesome. Autologous chondrocyte
implantation (ACI), first reported in 1994 by Brittberg
et al., was introduced as an alternative means of treating
symptomatic full-thickness chondral lesions of the knee
[1]. After ACI, cartilage repair tissue consists mainly of
cartilage-like tissue that mimics the macroscopic, micro-
scopic, and biomechanical features of healthy hyaline
cartilage [2, 3]. Magnetic resonance imaging (MRI) is the
most reproducible and least aggressive technique for
assessing cartilage regeneration after ACI. One validated
scoring system for the morphologic MRI evaluation of
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Observation of Cartilage Repair Tissue (MOCART) system
[4, 5]. Although satisfactory results in mid-term pain relief
have been reported [6], only a limited number of studies
have examined the long-term results of ACI in terms of
clinical assessment, patient satisfaction, and magnetic
resonance imaging (MRI) results [7–13].
The purposes of the study reported in the present paper
were therefore to:
• Evaluate the overall long-term results of ACI in terms
of clinical assessment, patient satisfaction, and mag-
netic resonance imaging (MRI) results
• Compare the long-term with the short-term clinical
results
• Evaluate the correlation between the subjective clinical
outcome and the radiological MOCART scoring system
and its variables.
Materials and methods
Between 1997 and 2001, 15 patients (nine men and six
women), with a mean age of 21 years (range 13–45),
underwent autologous chondrocyte implantation using the
original periosteum-cover technique. All patients had knee
pain and had decreased their physical activity due to the
presence of a chondral defect in the concerned knee. A
symptomatic full-thickness cartilage lesion (Outerbridge
grade III or IV) or an osteochondral lesion (2–12 cm2) was
considered an indication for ACI. Exclusion criteria were
age [45 years, prolonged osteoarthritis (Kellgren–Lawr-
ence grade 2 or more), obesity (BMI[ 35 kg/m2), a kiss-
ing lesion, active inflammatory arthritis or infection,
varus/valgus alignment[5, and/or untreated knee insta-
bility. No patient had undergone any previous surgical
attempts to treat the chondral defect, except for one case in
which a meniscectomy was performed together with a
chondral debridement for a patellar lesion. A trauma was
the cause of the chondral defect in eight cases, whilst
osteochondritis dissecans was the underlying cause in
seven cases. Patients with osteochondritis dissecans were
rated International Cartilage Repair Society (ICRS) stage 2
(partial discontinuity, stable on probing) or 3 (having an
unstable but not dislocated fragment). The mean size of the
lesion surface was 5.08 ± 2.01 cm2 (range 2–9 cm2).
Lesions were localized on the medial femoral condyle in 10
cases, on the lateral femoral condyle in two cases, on the
patella in two cases, and on the tibial plateau in one case.
During the first arthroscopic step, three partial meniscec-
tomies (two medial and one lateral) were performed, while
an anterior cruciate ligament (ACL) reconstruction and a
patellar alignment (Tables 1, 2) were performed during the
implantation of chondrocytes. All individuals provided oral
and written informed consent for the publication of their
individual clinical details in this paper; this was approved
by the institutional review board of our department and is
compliant with the Declaration of Helsinki.
Surgical technique
The ACI technique consisted of a two-step procedure, as
originally described by Brittberg [1]. First, an arthroscopy
was performed, where small pieces of full-thickness car-
tilage were harvested from a low-weight-bearing area of
the trochlea or from the upper area of the medial condyle;
these pieces weighed approximately 200–300 mg. The
biopsy material was placed in a nutrient medium and
transported within 24 h to a chosen laboratory. Chondro-
cytes were isolated from the cartilage by enzymatic treat-
ment, and the number of chondrocytes was increased via
Table 1 Patient demographic characteristics as well as prior and
concomitant procedures
Patient characteristic N = 15
Age, years







Procedures performed concurrently with cartilage harvest
Medial meniscectomy 2/15
Lateral meniscectomy 1/15




Table 2 Characteristics of chondral lesions
Defect characteristic
Acute traumatic injury 8/15
Osteochondritis dissecans 7/15
Total surface area, cm2
Mean ± SD 5.08 ± 2.01
Range 2–9
Defect location
Medial femoral condyle 10/15
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monolayer culture, as described previously [1]. After
3–4 weeks, an autologous pool of chondrocytes was ready
to be implanted. The surgical approach used in the
implantation step of the procedure depended on the size
and location of the defect: a medial or lateral parapatellar
arthrotomy was performed. Defect edges were marked and
then cut using a surgical blade, creating a contained lesion
with surrounding healthy cartilage. In all cases with
osteochondritis dissecans, the lesion was identified and the
fragment was removed along with fibrous tissue and
degenerated bone until healthy, bleeding bone was reached.
A periosteal flap was harvested from the proximal medial
subcutaneous border of the tibia. An incision was made
about 3 cm below the insertion of the pes anserinus. With
the inner cambium layer facing the lesion, the periosteal
flap was sutured to the surrounding cartilage using inter-
rupted absorbable sutures. The periosteal rim was sealed
with fibrin glue except for one corner, where the suspen-
sion of cultured chondrocytes (Carticel) was injected into
the defect. The implant was completed by closing the
corner with a final suture and the fibrin glue.
Postoperative rehabilitation protocol
The goal of rehabilitation was to protect the graft while
promoting maturation of the newly implanted chondrocytes
by implementing a program that focused on regaining full
range of motion (ROM), progressive weight bearing, lower
extremity strengthening, flexibility, and proprioceptive
training. In particular, when at least 24 h had passed fol-
lowing surgery, the knee was mobilized with the help of a
continuous passive motion (CPM) machine. Weight-bear-
ing activity was typically barred until after the first 2 weeks
of implantation in order to preserve the physical properties
of the graft. Partial weight bearing was then permitted until
4 weeks after surgery. From 4 to 6 weeks after surgery, the
patient could progress to the use of one crutch, with the
load gradually increased over the subsequent 6 weeks so
that full weight bearing had occurred by week 12. By
3 months after surgery, the patient had recovered their full
active range of motion with a normalized gait pattern. At
6–9 months after surgery, the patient continued progressive
strength training and transitioned to more functional
activities. From 9 to 18 months after surgery, the goal of
the rehabilitation was to implement sports-specific activity
and eventually facilitate the return of the patient to
competition.
Clinical evaluation
The International Knee Documentation Committee (IKDC)
Knee Examination Form [14, 15] and the Tegner Activity
Level Score [16] were used to perform clinical and
functional evaluation at baseline. Before the surgical pro-
cedure/surgery, all of the patients underwent a physical
examination, and weight-bearing standing radiographs as
well as magnetic resonance images (MRIs) of the affected
knees were recorded. Follow-up was accomplished in all
patients for a mean period of 148.1 ± 15.76 months (range
125–177 months). Each year, a clinical evaluation was
performed. At the final follow-up, functional evaluation
was performed with the IKDC Knee Examination Form,
the Tegner Activity Level Score, and the Knee Injury and
Osteoarthritis Outcome Score (KOOS) (Italian version LK
1.0) [17, 18]. Cases in which further surgery was per-
formed after ACI were defined as treatment failures.
Radiological evaluation
Thirteen of the patients periodically underwent magnetic
resonance imaging (1.5 T, Siemens Symphony) according
to the following acquisition protocol:
• Axial TSE PD FS 2D 1-7/180 (TE 37, TR 2500, matrix
192 9 256, FOV 180 9 180).
• Sagittal TSE PD FS 2D 1-7/180 (TE 38, TR 2000,
matrix 240 9 320, FOV 180 9 180).
• Coronal TSE PD FS 2D 1-7/180 (TE 37, TR 2000,
matrix 256 9 256, FOV 180 9 180).
• Sagittal TSE PD 2D 1-7/180 (TE 38, TR 2000, matrix
240 9 320, FOV 180 9 180).
• Sagittal 3D spoiled GRE T1 (Fi 3D 1/40) (TE 8, TR 34,
matrix 192 9 256, FOV 180 9 180).
The mean time of the first MRI after the implantation
was 12 months (range 6–30 months). At final follow-up
after a mean of 148.1 months (range 122–175 months), 11
patients were studied using a high-field MRI instrument
(3 T, Siemens Magnetom Trio) that was available at the
time in the radiologic department of our institution. The
examination was performed with a dedicated knee coil.
The acquisition protocol was as follows:
• Axial TSE PD FS (TE 11, TR5890, matrix 256 9 256,
thickness 3 mm, FOV 160 9 160).
• Sagittal TSE PD FS (TE 11, TR4660, matrix
320 9 320, thickness 3 mm, FOV 160 9 160).
• Coronal FFE 3D T1 hi-res VIBE (Te5, Tr14,2, FA 25,
slice thickness 0.6, matrix 512 9 512, FOV
150 9 150).
• Sagittal FFE DP 3D hi-res (Te232, Tr2200, matrix
230 9 250, FA 120, slice thickness 0.8, FOV
162 9 181).
• Sagittal T2 3D hi-res (Te4.9, Tr11, matrix 480 9 512,
slice thickness 0.6, FA 40, FOV 140 9 150).
The images were evaluated by an expert radiologist
according to the MOCART scoring system.
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Statistical analysis
Paired sample t-tests were used to determine whether fol-
low-up data were significantly increased or decreased from
the baseline clinical scores. In this context, the MRI score
after short-term follow-up was compared with the long-
term follow-up MOCART score by paired t-test. To
determine the correlation between clinical outcome and
MRI score, the KOOS and the IKDC scores were corre-
lated with the MOCART score and with the nine variables
of the MRI scoring system. For the statistical analysis,
Spearman’s correlation coefficient (rs) and Student’s t-test
were calculated. To evaluate the relationships of the
MOCART score and some of its variables (degree of defect
filling, integration of border zone, surface of the repair
tissue, structure of the repair tissue, signal intensity of the
repair tissue) with the KOOS variables and those of the
IKDC, Spearman’s correlation coefficient was calculated
considering the ranks of the variables, not their numerical
values. An independent samples t-test was used for the
remaining MOCART variables (subchondral lamina, sub-
chondral bone, adhesions, effusion). All tests were per-
formed using the statistical software package R (R
Development Core Team, 2005). In all instances, P\ 0.05
was regarded as statistically significant.
Results
All 15 patients were retrospectively followed up after ACI
for a mean period of 148.1 ± 15.76 months (range
125–177 months). Two patients (13.3 %) needed an oper-
ation after ACI, entailing removal of the graft and treat-
ment of the defect with microfractures. Failure was in both
cases due to partial detachment of the graft and degener-
ation of the graft area. The graft site was also filled with
fibrous tissue that was partially lifted at its medial aspect,
exposing the subchondral bone. The defect area was deb-
rided from the fibrous tissue and the chondral lesion was
exposed. The microfracture technique was then performed
as a treatment for the lesion. At the final follow-up, sig-
nificant increases in all scores were recorded. Compared
with the pre-procedure findings, the mean IKDC score
improved significantly, increasing from 37.20 ± 19.54 to
76.32 ± 32.36 (P = 0.000314) (Fig. 1). The Tegner
Activity Level Score showed significant improvement after
surgery, increasing from 2.33 ± 1.34 to 4.93 ± 2.43
(P = 0.0011) (Fig. 2). The KOOS scores were as follows:
pain 79.63 ± 33.33; symptoms 76.42 ± 32.47; ADL
85.09 ± 34.62; sport 70.33 ± 31.13; knee-related quality
of life 74.17 ± 32.72. The mean MOCART score at the
first follow-up was 55 ± 26.53, whereas that at the last
follow-up was 45 ± 31.62. Ten patients underwent MRI at
both short-term and long-term follow-ups; the paired t-test
showed a significant decrease in the MOCART score from
59 ± 29.13 to 43.5 ± 32.91 (P = 0.0226) (Fig. 3).
Table 3 shows the results for each variable of the
MOCART score at both short-term and long-term follow-
ups. The correlation coefficients and the results of the t-test
for subjective outcomes and the different variables of the
MRI classification system indicated that there were statis-
tically significant correlations between degree of defect
repair and pain KOOS as well as between effusion and the
pain and symptoms KOOS (p\ 0.05).
Discussion
In this study, we evaluated the durability of ACI in patients
treated for full-thickness cartilage defects. The most
important finding of our study was confirmation of the
long-term effectiveness of ACI, even up to 14 years after
the first implantation performed in our center. Clinical and
functional improvements, with significantly increased
mean IKDC and Tegner Activity Level scores, were
observed in 86.6 % of cases. A functional evaluation was
also performed using the Knee Injury and Osteoarthritis
Outcome Score (KOOS) at final follow-up. The KOOS
results were compared with the age-specific KOOS scores
for the general population, as obtained in the epidemio-
logical study of Paradowski et al. [19]. The mean KOOS
scores for the 18–34 year-old age group were 92.2 men/
92.1 women for pain, 87.2 men/89.1 women for symptoms,
94.2 men/95.2 women for ADL, 85.1 men/86.4 women for
sports, and 85.3 men/83.6 women for quality of life. At the
Fig. 1 IKDC score: improvement from pre-operative levels to final
follow-up
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final follow-up evaluation, our patients had a mean age of
33.6 years and, if the two failed implantations are exclu-
ded, the average KOOS scores were 95.1 men/86.6 women
for pain, 93.3 men/80 women for symptoms, 97.8 men/98.8
women for ADL, 88.7 men/69 women for sport, and 89.1
men/80 women for quality of life. The KOOS results
obtained in our study are comparable with the results of
Paradowski et al. [19]. The increases observed in all clin-
ical and functional scores at the last follow-up might be
related to the young age of the study population at the time
of ACI. Indeed, the mean age of the participating patients
was 21.33 years (range 13–45), 10 years less than the
average age of patients in other studies [10–12].
With only 2 failures (13.3 %), the results of the pre-
sent study compare favorably with other such reports in
the literature [2, 9, 11]. Our treatment failure rate was
rather low compared with the reported rates of 16–24 %
observed in comparable treatment settings [8, 17]. The
two failures occurred in our study due to early deterio-
ration of the graft site; this complication always leads to
clinical failure and a new intervention always becomes
necessary. In both cases, it became necessary to remove
the graft and treat the osteochondral damage with
microfractures [20]. Four of our patients (26.6 %)
showed hypertrophy of the graft on MRI at first radio-
logic follow-up, but in none of those cases was it
symptomatic, so we did not perform a second-look
arthroscopy in any of these cases. Transplant hypertrophy
is a complication associated with the use of periosteum
[20–23]. Thus, several modifications of the initial tech-
nique, such as periosteal flap peeling or flap substitution
with synthetic membranes or fibrin matrix, were pro-
posed to minimize its incidence and attain satisfactory
results [21, 23].
In addition to providing data on long-term clinical out-
comes, our study also contributes information on MRI
assessment. MRI is a noninvasive method for assessing
structural repair outcomes, and is considered the most
effective tool for evaluating the internal structures of the
knee joint. A second look via arthroscopy would enable
better evaluation of the obtained repair tissue, but the
invasive nature of this procedure would not allow it to be
performed daily in a clinical setting. Moreover, the risks
associated with such an invasive approach are not accept-
able for ethical reasons, in particular for patients with
satisfactory outcomes. It may only be justifiable in cases of
failed treatment when the patient needs further cartilage
treatment. In our study, second-look arthroscopy was only
performed in two patients for whom ACI failed.
The cartilage and ACI graft were assessed with 3D
sequences, which provided superior spatial resolution,
aiding definition of the defect filling, the integration of the
graft with the underlying bone and adjacent native carti-
lage, and the status of the subchondral bone and bone
marrow. To describe the repair tissue, we used the previ-
ously published MOCART classification [8]. We used the
MOCART score to evaluate the results after a mean fol-
low-up period of 148.1 months. We compared the MRI
findings with the clinical outcomes. Initially, the MRI
variables were correlated with the subjective patient eval-
uation using the KOOS and IKDC scoring systems. Sta-
tistically significant correlations between the clinical
outcome and some of the radiological variables were
found. A statistically significant correlation of filling of the
defect with KOOS pain was observed (P\ 0.05). Effusion
was statistically significantly correlated with KOOS pain
Fig. 2 Tegner score: improvement from pre-operative levels to final
follow-up
Fig. 3 MOCART score: comparison of MOCART score at
12 months with that at final follow-up
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and symptoms (P\ 0.05). No statistically significant cor-
relation was found for the other variables.
Marlovits et al. compared clinical scores with MRI
variables and found statistically significant correlations
with only four of the nine MOCART variables (filling of
the defect, structure of the repair tissue, subchondral bone,
signal intensity of the repair tissue) [5]. Our study evalu-
ated MRI images at long-term follow-up for only ten knees
and compared these data with images taken at the first
follow-up. Among the nine variables of the MOCART
scoring system, only one remained unchanged over time:
the surface of the repair tissue. Patients who had complete
or hypertrophic filling at the first follow-up presented a
stable degree of defect repair over time, whilst the others
who had incomplete filling showed a deterioration in the
score for this variable at last follow-up (Table 3). The
observed reductions in MOCART variable scores can be
explained by graft aging and the alteration of the whole
joint. The MOCART variables that were more likely to
show reduced scores were those linked to the underlying
Table 3 MRI evaluation of
repair tissue 1–2 years and
10 years after ACI implantation
Variables First follow-up Last follow-up
1. Degree of defect repair and filling of the defect
Complete 2/10 (20 %) 2/10 (20 %)
Hypertrophy 4/10 (40 %) 4/10 (40 %)
Incomplete
[50 % of the adjacent cartilage 3/10 (30 %) 0/10 (0 %)
\50 % of the adjacent cartilage 0/10 (0 %) 1/10 (10 %)
Subchondral bone exposed 1/10 (10 %) 3/10 (30 %)
2. Integration to border zone
Complete 7/10 (70 %) 4/10 (40 %)
Incomplete
Demarcating border visible (split-like) 0/10 (0 %) 1/10 (10 %)
Defect visible
\50 % of the length of the repair tissue 1/10 (10 %) 2/10 (20 %)
[50 % of the length of the repair tissue 2/10 (20 %) 3/10 (30 %)
3. Surface of the repair tissue
Surface intact 5/10 (50 %) 5/10 (50 %)
Surface damaged
\50 % of repair tissue depth 2/10 (20 %) 2/10 (20 %)
[50 % of repair tissue depth or total degeneration 3/10 (30 %) 3/10 (30 %)
4. Structure of the repair tissue
Homogeneous 3/10 (30 %) 1/10 (10 %)
Inhomogeneous or cleft formation 7/10 (70 %) 9/10 (90 %)
5. Signal intensity of the repair tissue
Normal (identical to adjacent cartilage) 3/10 (30 %) 2/10 (20 %)
Nearly normal 5/10 (50 %) 5/10 (50 %)
Abnormal 2/10 (20 %) 3/10 (30 %)
6. Subchondral lamina
Intact 2/10 20 %) 1/10 (10 %)
Not intact 8/10 (80 %) 9/10 (90 %)
7. Subchondral bone
Intact 4/10 (40 %) 1/10 (10 %)
Not intact 6/10 (60 %) 9/10 (90 %)
8. Adhesions
No 8/10 (80 %) 2/10 (20 %)
Yes 2/10 (20 %) 8/10 (80 %)
9. Effusions
No 8/10 (80 %) 6/10 (60 %)
Yes 2/10 (20 %) 4/10 (40 %)
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bone alteration and to the presence of adhesions. The
health and integration of the patch were seen to be com-
promised in a few cases. Those variations are probably
linked to inflammation, which can be present in a joint that
does not work optimally; moreover, the new cartilage is
probably less strong than that surrounding it. Perhaps a
longer follow-up period, although difficult to implement,
may reveal if the MOCART score plateaus after decreasing
or if it continuously decreases.
In conclusion, first-generation ACI seems to be an
effective and durable treatment for large, full-thickness
chondral and osteochondral defects of the knee. ACI pro-
vides satisfactory results in terms of both pain relief and
knee function rehabilitation, which appear to be sustained
in the majority of patients according to long-term follow-
up results. Magnetic resonance imaging plays an important
role during the post-procedure follow-up of cartilage repair
procedures, as it permits accurate and noninvasive assess-
ment of the status of cartilage repair, even though there is
no significant linear correlation between the overall MRI
score and the subjective and objective knee scores.
Some limitations of our study need to be acknowledged.
Treatment effects may have been overestimated or under-
estimated because of the lack of a control group. Com-
parison to a control group would aid accurate
interpretation, as it would allow the spontaneous evolution
of untreated lesions of a similar size to be evaluated. The
literature provides only very limited data on patients with
untreated cartilage lesions [24]. Cicuttini et al. suggested
that full-thickness cartilage lesions in young patients may
provoke early osteoarthritis over time [25]. To obtain more
reliable data, a second study arm of patients with healthy
knees or untreated chondral lesions would be of special
interest. However, it should be remembered that such a
control group would be difficult to create due to ethical
considerations, and this remains a limitation of our analysis
and other analyses of the long-term outcomes of ACI and
other treatment options [2, 8, 7].
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